BioOra, New Zealand’s pioneering licensed contract and development manufacturer of CAR T cell therapeutics, has successfully raised an impressive $4 million in funding to advance its groundbreaking work in cell therapy. This significant investment underscores the growing recognition of BioOra's unique capabilities and commitment to delivering cutting-edge therapeutics to patients worldwide. With a world-class team of scientists and industry consultants, BioOra is dedicated to streamlining the journey of CAR T cell therapies – from patient blood isolation to the crucial stage of infusion. The newly acquired funds will enable the company to enhance its manufacturing processes, further control costs, and expedite timelines, ultimately allowing for faster patient access to vital therapies. In addition to bolstering operational efficiency, BioOra plans to invest in continuous improvement initiatives that will strengthen their already robust capabilities as they advance therapies through commercialization. This investment not only marks a significant milestone in BioOra’s growth but also reflects the company's unwavering commitment to innovation in the field of cell therapy. As it forges ahead, BioOra is poised to reshape the landscape of CAR T cell treatments, ensuring that therapeutic advancements are both accessible and adaptable to the evolving needs of patients globally. With this funding, BioOra is not just investing in its future – it is investing in the future of medicine.
BioOra Secures $4 Million in Funding to Revolutionize CAR T Cell Therapeutics Manufacturing in New Zealand
Get the full BioOra company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Mantle8
We are a new generation of geologists leading the energy revolution by locating the Earth’s naturally occurring hydrogen reservoirs. Using bottom-up exploration and decades of geology experience, we are on a mission to deliver natural hydrogen to the world. Check out this short video explainer for more details: https://vimeo.com/1116223132
$36.6M Series a
today
Data Mission
We build purpose-driven tools that help cities and counties work smarter - from RFP creation and cost estimation to budgeting, workforce planning, and community insights. Our platform replaces spreadsheets and manual workflows with intelligent, transparent systems tailored to the complexities of local government. Whether you’re planning capital projects, managing procurement, or forecasting community needs, we give public agencies the clarity and confidence to lead with data.
$1.0M Seed
today
SiteVue AI
Empowering the frontline worker with AI to drive automated continuous improvement while improving safety and employee engagement.
$7.0M Seed
today
Peekabox
Peekabox is a food-tech platform helping bakeries, restaurants, and grocery stores across the GCC sell their surplus food at 50-70% off. Every day, thousands of freshly prepared food items are thrown away across the region. In the UAE alone, over $3.5 billion worth of food is wasted annually, 38% of everything prepared daily ends up in the bin. That's a massive problem for retailers, consumers, and the planet. We partner with leading F&B brands and retailers to list their unsold surplus as surprise boxes on our platform. Customers reserve and collect them in-store at guaranteed minimum discounts of 50%. Retailers turn waste into revenue. Consumers get quality food at a fraction of the price. Everybody wins. 1,000+ stores signed across 50+ brands including Costa, Carrefour, Tim Hortons, Dunkin', Paul, Armani Cafe, Eataly, Pret A Manger, Krispy Kreme, Address Hotels, and many more. Backed by some of the most prominent business leaders in the region, chaired by Dr Sameer Al Ansari, Former CFO of H.H Sheikh Mohammed's Executive Office and former CEO Dubai International Capital. For consumers → Download Peekabox and start saving on food from your favourite stores. For partners → List your surplus in 15 seconds and turn food waste into revenue. Get in touch → hello@peekabox.co
$1.5M Pre-seed
today
Aumet inc
Aumet is dedicated to providing tailored solutions that enhances the performance of healthcare providers, operating in Saudi Arabia, Jordan, Egypt and Oman It is a Saudi company that was Originally established in the United States, Aumet is now the largest B2B healthcare solution provider that supports companies with their business decisions and performance. Aumet facilitates the exchange of data between healthcare providers, manufacturers, and distributors to enable them to take the right decision.
$12.0M Series a
today